Google.org

SandboxAQ is a company that develops artificial intelligence and quantum technology solutions aimed at addressing complex business and scientific challenges. By integrating expertise from multiple disciplines, including physics, computer science, and mathematics, the company creates Large Quantitative Models and AI sensing applications tailored for various industries. Its offerings are designed to provide practical solutions in sectors such as financial services, healthcare, telecommunications, and cybersecurity. Through its innovative software, SandboxAQ enables clients to tackle significant computational challenges and advance their technological capabilities.

Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve overall efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights to support providers in their clinical and operational tasks.

Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.

Synapticure is a virtual clinical care platform dedicated to supporting patients with neurodegenerative diseases, including dementia, Parkinson's, and ALS, throughout the United States. Founded by patients, the company offers comprehensive care services that include access to disease-specific neurologists, speech and language therapy, and 24/7 care coordination. Utilizing advances in science, technology, and computational analytics, Synapticure ensures that patients receive tailored treatment and support in their own homes. The platform integrates medical, dental, vision, and life insurance plans to facilitate easy access to a range of healthcare services, including behavioral health support such as psychiatry and therapy, all aimed at enhancing the quality of life for individuals facing these challenging conditions.

Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

Diverge Health is a healthcare platform designed to support primary care practices in providing quality care to underserved patients. The company enhances these practices by offering a robust infrastructure that includes highly trained community health teams and administrative support. Additionally, Diverge Health integrates technology to facilitate local population health management. This comprehensive approach enables primary care providers to achieve better health outcomes for their patients while successfully navigating the shift towards value-based payment models.

Jacaranda Health is a medical services provider in Kenya, specializing in maternal and child health. It operates clinics in underserved, peri-urban areas, offering high-quality, affordable care, including maternity services, general healthcare, and nursing mentorship. Jacaranda's services are designed to be patient-centered and cost a fifth of what private hospitals charge. Notably, the company has achieved a zero maternal mortality rate, significantly lower than Kenya's national average of 400 deaths per 100,000 births. Additionally, Jacaranda Health is involved in research and innovation to improve maternal and newborn health services.

PeopleOne Health specializes in providing comprehensive healthcare solutions that integrate treatment and prevention, leading to substantial cost savings for both employers and employees. By focusing on value-based primary care, the company enables employers to save up to 30% on healthcare expenses while improving employee recruitment and retention. Employees benefit from an award-winning health program at no cost, which includes access to a dedicated team of top-tier healthcare professionals. PeopleOne Health designs and implements tailored corporate wellness programs for medium and large organizations, empowering employees to manage their health risks and stay informed about wellness opportunities. The company's commitment to customer satisfaction is reflected in an impressive net promoter score exceeding 90, significantly higher than the healthcare industry average.

Infinitus Systems is an AI healthcare company focused on automating phone-based processes to enhance efficiency within the healthcare ecosystem. By streamlining tedious and time-consuming communication tasks, Infinitus aims to improve access to therapy, adherence, and affordability for patients. The company's innovative tool allows users to submit call requests easily, track updates, and receive notifications upon task completion. Infinitus Systems has raised $51.4 million in funding from prominent investors, including Kleiner Perkins, Coatue, and Google Ventures. Through its automation solutions, the company seeks to reduce the complexity and costs associated with back-office administration in the healthcare sector.

Ubie, Inc. is a Tokyo-based company founded in 2017 that specializes in developing artificial intelligence-driven healthcare solutions. Its primary product is an AI symptom checker, designed to aid hospitals and physicians by delivering individualized evaluation reports based on patient responses to a brief questionnaire. The system tailors its questions according to various factors, including biological sex, age, medical history, and lifestyle choices. By providing a patient summary and predictive diagnosis, Ubie's technology enhances the diagnostic process, facilitating more personalized care for patients.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, automates revenue cycle management by interpreting clinical language in patient charts and accurately assigning medical charge codes, reducing operational expenses, improving payment cycles, and enhancing audit readiness. Nym's solution identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. The company also has a research and development center in Tel Aviv-Yafo, Israel.

PGxAI is an AI-powered pharmacogenetics platform that redefines precision medicine using proprietary algorithms and real-world data. Partnered with InterSystems, the largest patient data holder globally, and leveraging advanced tools like VectorSearch and GenAI, PGxAI accesses extensive real-world data to solve drug selection, dosage personalization, and identification of clinically relevant drug-drug interactions.

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.

Santa Ana Bio is a biotechnology company focused on developing precision therapies for autoimmune and inflammatory diseases. By utilizing advanced technologies such as deep cell profiling, single-cell genomics, and multi-omics platforms, the company designs targeted biologics that aim to provide effective and personalized treatment options. Through its innovative approach, Santa Ana Bio seeks to enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.

AccuLine is a digital healthcare company focused on preventing heart attacks by offering innovative solutions for early detection of coronary artery disease (CAD). The company is developing CORA, a non-invasive examination technology that provides a smart, accurate, and user-friendly alternative to traditional stress tests. By streamlining the detection process, CORA enables healthcare providers to identify CAD more swiftly and cost-effectively, ultimately aiming to save millions of lives worldwide through timely intervention.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.

Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

Comanche Biopharma is a biopharmaceutical company focused on developing an investigational small interfering RNA (siRNA) medicine aimed at treating preterm preeclampsia. The company is committed to ensuring that all women and their babies have access to safe and effective therapies for life-threatening complications during pregnancy. Comanche Biopharma's mission emphasizes the importance of evidence-based and affordable solutions, enabling women to receive cost-effective treatments that address the root causes of preeclampsia.

Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company is creating a profiling and engineering technology platform that leverages advanced artificial intelligence to deliver an in-depth understanding of the epigenome in both health and disease. This innovative approach allows healthcare providers to explore new avenues for therapy discovery and facilitates the reprogramming of cells to restore their healthy state. By integrating AI-driven insights, Moonwalk Biosciences aims to transform the landscape of therapeutic development and improve patient outcomes.

Onward Assist operates an advanced cancer prognostics platform aimed at enhancing treatment decisions for oncologists and ultimately improving patient outcomes. The platform employs machine learning and computer vision to provide automated diagnostic tools and treatment decision support specifically designed for histopathologists, radiologists, and oncologists. Its flagship product, PathAssist, integrates an AI layer with automated diagnostics in histopathology, a pathology workflow solution, and a cost-effective slide digitization hardware. By analyzing and predicting the behavior of cancer cells, Onward Assist facilitates deeper insights into tumors and surrounding tissues, thereby ensuring more accurate prognoses and effective treatment protocols.

Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

YMCA of Metropolitan Dallas is a religious organization that focuses on youth development, healthy living, and social services. The organization was founded in 1885 and is based in Irving, Texas. YMCA of Metropolitan Dallas operates as a subsidiary of Ymca Of Greater Pittsburgh.

Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve overall efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights to support providers in their clinical and operational tasks.

Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Wadhwani AI is a non-profit research institute based in India that develops artificial intelligence solutions aimed at addressing social challenges. The organization focuses on several key sectors including healthcare, agriculture, education, infrastructure, and financial inclusion. It aims to create AI-based innovations such as early pest warning systems, maternal and child health initiatives, and tuberculosis eradication strategies. By engaging directly with local communities and stakeholders, Wadhwani AI fosters a deep understanding of the unique challenges faced by underserved populations. The institute measures its success by the positive impact it generates in improving the lives of economically challenged communities, leveraging its global perspective to create solutions that can be adapted worldwide.

Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

IDinsight with Reach Digital Health developed a natural language-enabled question-and-answer service for pregnant moms that delivers responses to questions as well as important health information.

Jacaranda Health is a medical services provider in Kenya, specializing in maternal and child health. It operates clinics in underserved, peri-urban areas, offering high-quality, affordable care, including maternity services, general healthcare, and nursing mentorship. Jacaranda's services are designed to be patient-centered and cost a fifth of what private hospitals charge. Notably, the company has achieved a zero maternal mortality rate, significantly lower than Kenya's national average of 400 deaths per 100,000 births. Additionally, Jacaranda Health is involved in research and innovation to improve maternal and newborn health services.

Causal Foundry is a personalization to solve the greatest challenges in healthcare and medicine.

RAD-AID International is dedicated to improve radiology services in the developing world and poor areas.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

Nimbus Therapeutics, based in Cambridge, Massachusetts, is a biotechnology company focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. The company utilizes advanced computational technologies to create selective and potent small-molecule therapeutics. Among its notable projects is the Nimbus Apollo program, which features the lead candidate NDI-010976, an allosteric inhibitor targeting Acetyl-CoA Carboxylase (ACC). This compound is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and has potential applications in hepatocellular carcinoma (HCC) and other diseases. NDI-010976 received Fast Track designation from the U.S. Food and Drug Administration in 2016, highlighting its significance in the clinical development pipeline. Nimbus Therapeutics has formed strategic partnerships to enhance its research and development capabilities, reinforcing its commitment to advancing treatment options for complex health challenges.

Delve Bio is a biotechnology company focused on delivering molecular insights to enhance precision patient care. It specializes in the pathogen-agnostic and unbiased detection of neuro-infectious pathogens in cerebrospinal fluid (CSF). By providing comprehensive diagnostic solutions in a single test, Delve Bio equips laboratories and clinicians with critical information necessary for identifying both common and rare infectious diseases, thereby facilitating more accurate and timely medical interventions.

Caraway is a digital healthcare company for college women+ that provides integrated mental, reproductive and physical healthcare services. Built with students for students, Caraway arms women+ with the first personalized, equitable and digitally-accessible care solution that prioritizes their needs and concerns. With an unprecedented need for mental health resources and new barriers and persistent inequities in women’s+ health, Caraway provides access to trusted, holistic, and compassionate healthcare so women+ can get the care they need when they need it.

Bitterroot Bio is a biotechnology company focused on developing innovative immunotherapy-based treatments for cardiovascular disease. By harnessing the immune system's natural capabilities to combat illness, the company conducts research to understand the significant roles of immune cells and immune modulators in the onset and advancement of cardiovascular conditions. Through its commitment to advancing medical treatments, Bitterroot Bio aims to provide effective therapies that can transform cardiovascular disease management and improve patient outcomes.

Comanche Biopharma is a biopharmaceutical company focused on developing an investigational small interfering RNA (siRNA) medicine aimed at treating preterm preeclampsia. The company is committed to ensuring that all women and their babies have access to safe and effective therapies for life-threatening complications during pregnancy. Comanche Biopharma's mission emphasizes the importance of evidence-based and affordable solutions, enabling women to receive cost-effective treatments that address the root causes of preeclampsia.

Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.

Clever Care Health Plan, Inc. is a healthcare insurance provider that specializes in Medicare Advantage plans, integrating the principles of Eastern and Western medicine. Founded in 2018 and headquartered in Westminster, California, with an additional office in Arcadia, the company offers a range of culturally sensitive healthcare solutions. Its plans include access to services such as acupuncture, herbal remedies, tai chi, and cupping, aimed at enhancing both physical and mental well-being. Clever Care connects its members with diverse networks of hospitals and healthcare providers who are attuned to their cultural needs and language preferences. The company distributes its products through brokers and sales agents, ensuring that Medicare beneficiaries receive the support and services they require.

MedTourEasy, a global healthcare company, provides you the informational resources needed to evaluate your global options. MedTourEasy provides analytical solutions to our partner healthcare providers globally.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Santa Ana Bio is a biotechnology company focused on developing precision therapies for autoimmune and inflammatory diseases. By utilizing advanced technologies such as deep cell profiling, single-cell genomics, and multi-omics platforms, the company designs targeted biologics that aim to provide effective and personalized treatment options. Through its innovative approach, Santa Ana Bio seeks to enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.

Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.

Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Britto's Brainwaves is a healthcare company that emerges as a beacon for those seeking in-depth medical insights.

Wadhwani AI is a non-profit research institute based in India that develops artificial intelligence solutions aimed at addressing social challenges. The organization focuses on several key sectors including healthcare, agriculture, education, infrastructure, and financial inclusion. It aims to create AI-based innovations such as early pest warning systems, maternal and child health initiatives, and tuberculosis eradication strategies. By engaging directly with local communities and stakeholders, Wadhwani AI fosters a deep understanding of the unique challenges faced by underserved populations. The institute measures its success by the positive impact it generates in improving the lives of economically challenged communities, leveraging its global perspective to create solutions that can be adapted worldwide.

The Indian Institute of Technology Madras is a public technical and research university. It offers undergraduate, postgraduate, and doctoral programs across various engineering, science, and humanities disciplines. The institute focuses on research and innovation, contributing to advancements in technology and education. It serves industries such as information technology, manufacturing, energy, and healthcare.

Galileo, Inc. is a technology company that specializes in providing healthcare solutions through a mobile application, enabling direct access to clinical care and expertise via smartphones. Founded in 2014 and headquartered in New York, the company facilitates communication between healthcare providers and patients using advanced telecommunications technologies. Galileo delivers high-touch, data-driven, multi-specialty care to a diverse patient population, offering services over the phone and in various settings. The company is recognized by regional and national health plans, employers, and major corporations for its effectiveness in enhancing population health. Galileo's mission is to address complex healthcare challenges and foster closer connections between patients and providers.

Carrick Therapeutics, Ltd., established in 2015 and headquartered in Dublin, Ireland, focuses on developing innovative cancer therapeutics aimed at transforming cancer treatment. The company targets molecular pathways associated with aggressive and resistant forms of cancer, employing advanced mechanisms to improve treatment outcomes. By enabling the detection of predictive biomarkers, Carrick Therapeutics facilitates the initiation of targeted therapies at early stages, ultimately striving to enhance the lives of cancer patients.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing male birth control solutions. The company is creating an innovative, long-lasting, non-hormonal, and reversible contraceptive known as Echo-V. This product consists of an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device acts as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and user-friendly approach to male contraception. Founded in 2015, Contraline aims to transform male reproductive health through its groundbreaking technology.

Sound Life Sciences, Inc. is a Seattle-based company that specializes in developing clinically validated software for mobile phones and smart speakers. Founded in 2018, the company has created a sonar-based, contactless respiratory monitoring system designed to detect dangerous health conditions, including overdose and cardiac arrest. The application enables devices to monitor breathing changes in various scenarios, thereby facilitating the management of chronic diseases and enhancing emergency response capabilities. With a focus on improving health outcomes, Sound Life Sciences aims to provide tools that support physicians in both wellness and environmental sensing contexts.

Pasito is a developer of a benefits enrollment platform focused on enhancing financial health through improved decision-making regarding health and pre-tax benefits. The platform aims to simplify the complex benefits market by providing tailored guidance and personalized support for employees, ensuring they can effectively navigate various programs such as HSA plans, supplemental medical insurance, and retirement accounts. By utilizing advanced algorithms and data, Pasito creates a more engaging employee experience that encourages participation in benefits packages throughout the year. Additionally, the platform serves as a point of contact for health plan selection and helps clients mitigate compliance risks, ultimately allowing organizations to better engage their workforce while reducing payroll and health premium costs.

ReflexAI develops artificial intelligence tools aimed at enhancing the training and performance of frontline teams across various sectors, including crisis services, emergency response, social services, and healthcare. The company's offerings focus on scalable AI solutions that provide advanced roleplay simulations and intelligent quality assurance, which improve outcomes for human interactions. By automating scoring and reporting processes, ReflexAI's tools help to optimize training efficiency while ensuring consistency and visibility, particularly in veteran mental health services. This approach not only saves time and resources but also empowers agents to deliver better support in critical situations.

Pretzel Therapeutics is a biotechnology company focused on developing therapies for mitochondrial dysfunction. Founded by leading experts in mitochondrial biology, the company aims to create innovative treatments that address the underlying causes of mitochondrial issues. By leveraging a comprehensive understanding of mitochondrial mechanisms, Pretzel Therapeutics seeks to reverse dysfunction at its roots, potentially providing effective solutions for patients suffering from a range of conditions, including those related to aging. The company's name reflects its scientific focus on the mitochondrion, which is characterized by its unique and highly folded inner membrane, distinguishing it from other organelles in the body.

Verily is an Alphabet health technology company focused on research, care, and health financing to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable. For more information about Verily please visit verily.com. The company was founded in 2015 and is based in San Francisco, California, United States.

Kindbody is a comprehensive fertility clinic network and family-building benefits provider that offers a wide range of services aimed at improving access to healthcare for women. The company provides both virtual and in-person care, including fertility assessments, education, preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. By partnering with employers, Kindbody delivers financial, medical, and emotional support to employees pursuing parenthood. The company serves more than 100 employers, covering over 2.4 million lives, while also providing direct fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. With a focus on affordability and accessibility, Kindbody employs modern technology to deliver holistic health and fertility services.

Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

Medallion is a company that offers a network management platform tailored for the healthcare industry, focusing on simplifying the complex processes of licensing, credentialing, and payer enrollment. Founded in 2020 by Derek Lo and based in San Francisco, California, Medallion's all-in-one platform addresses the logistical challenges that healthcare providers and telemedicine companies face, enabling them to minimize time spent on administrative tasks. Key features of the platform include facilities for new licensing and renewals, primary source verification, continuing medical education tracking, and document management. By streamlining these processes, Medallion allows healthcare professionals to concentrate more on patient care rather than paperwork.

Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.

Syrona Health is a digital health company focused on personalized gynecological care throughout various life stages, including menstrual health and menopause. The platform offers a virtual health support system combined with at-home clinical tests aimed at enhancing gynecological health outcomes. It addresses key women's health issues such as endometriosis, polycystic ovary syndrome (PCOS), fertility, parenthood, and menopause. By leveraging both software and hardware, Syrona Health enables women to monitor their health and receive online counseling, facilitating proactive management of their gynecological conditions without the need for lengthy diagnostic processes in clinics.

ZooZy is a mobile application designed to enhance pet care by providing health monitoring and activity tracking for pets. The app collects comprehensive data on pets, allowing owners to manage their pets' diets with precision instead of relying on rough estimates or expensive consultations. It offers 24/7 tracking of pets' health, sending alerts for any issues that may arise. Additionally, ZooZy facilitates the ordering of pet food and supplies through a regular home delivery service, streamlining the shopping experience. The platform also includes features that help users locate essential services such as grooming salons, veterinary clinics, and pet-related shops, ensuring that pet owners have reliable access to the resources needed for effective pet care. Overall, ZooZy aims to create a data-driven ecosystem that promotes longer, healthier, and happier lives for pets.

Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.

OMass Therapeutics Limited is a biotechnology company based in Oxford, United Kingdom, established in 2016. The company specializes in drug discovery, utilizing structural mass spectrometry technology to develop innovative therapeutics aimed at difficult disease targets. Its platform allows clients to access native mass spectrometry without the need for sophisticated instrumentation or in-house expertise. This capability enables the study of complex protein assemblies and their interactions with other biological molecules, facilitating the development of drugs and biotherapeutics. OMass Therapeutics aims to provide a dynamic and collaborative environment for biotechnology and pharmaceutical clients to address challenging drug targets effectively.

Waltz Health is focused on enhancing the pharmaceutical supply chain by collaborating with consumers, payers, and pharmacies to develop innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company creates AI-driven marketplaces that aim to reduce costs and provide valuable insights for users, facilitating informed decision-making in prescription care. By offering consumer tools designed to empower individuals and help payers manage their pharmacy benefits, Waltz Health strives to improve accessibility and affordability in the healthcare sector.

Viz.ai, Inc. specializes in healthcare imaging software designed to enhance stroke care through the use of artificial intelligence. The company's flagship technology synchronizes treatment by reducing delays in patient care, enabling rapid identification of large vessel occlusion (LVO) strokes using advanced deep learning algorithms. Key offerings include Viz LVO, which alerts on-call stroke teams based on CT angiogram images, and Viz CTP, which analyzes CT perfusion images and generates critical parametric data. Additionally, Viz HUB facilitates communication among clinical teams to coordinate care efficiently, while Viz VIEW allows healthcare professionals to view imaging data on mobile devices. Founded in 2016 and headquartered in San Francisco, the company aims to transform healthcare delivery by improving the speed and accessibility of treatment for stroke patients.

Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

Elly Health Inc. develops innovative audio companion software designed to support patients, healthcare providers, and organizations. The company's flagship product, Elly, serves as an empathetic audio companion for individuals managing chronic diseases. By leveraging technology, Elly motivates and offers guidance from experts and contributors, enhancing the support system for those living with chronic conditions. Founded in 2019 and based in Los Angeles, California, Elly Health aims to improve patient experience and engagement in healthcare.

Celsius Therapeutics is a biotechnology company focused on developing precision medicines for patients with cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a team of scientists, technologists, computational biologists, clinicians, and drug hunters. Utilizing single-cell genomic analysis and machine learning techniques, Celsius Therapeutics aims to discover and create innovative therapies that can lead to significant improvements in patient outcomes. The company's research efforts are centered on identifying new drug candidates that address unmet medical needs in the therapeutic landscape.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

Spotlight Therapeutics, Inc. specializes in the development of gene editing therapeutics designed to target specific cell populations directly within the body. Established in 2017 and based in Hayward, California, the company leverages a biotechnology platform that utilizes CRISPR nuclease effectors for in vivo gene editing. Its innovative approach aims to create next-generation programmable nucleases that enhance treatment options for a variety of conditions. Spotlight Therapeutics is focused on multiple therapeutic areas, including immuno-oncology, ophthalmology, and hematology, and is developing programs to address previously undruggable intracellular gene targets as well as specific monogenic disease targets related to the eye. This targeted gene editing strategy seeks to overcome the challenges associated with traditional delivery methods, thereby providing healthcare providers with improved tools for patient treatment.

DNAnexus, Inc. is a provider of cloud-based genome informatics and data management tools aimed at enterprises engaged in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and integration with clinical and phenotypic data, promoting seamless collaboration among users. Key offerings include MOSAIC Microbiome, a platform for collaborative microbiome research; DNAnexus Apollo, which focuses on clinico-genomic data exploration; and DNAnexus Titan, a comprehensive data analysis solution. Additionally, DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration. The Clinico-Genomic Data Solution program addresses the need for disease-specific datasets by building networks with healthcare partners to enhance diagnosis and treatment pathways. DNAnexus serves a diverse client base, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

Synapticure is a virtual clinical care platform dedicated to supporting patients with neurodegenerative diseases, including dementia, Parkinson's, and ALS, throughout the United States. Founded by patients, the company offers comprehensive care services that include access to disease-specific neurologists, speech and language therapy, and 24/7 care coordination. Utilizing advances in science, technology, and computational analytics, Synapticure ensures that patients receive tailored treatment and support in their own homes. The platform integrates medical, dental, vision, and life insurance plans to facilitate easy access to a range of healthcare services, including behavioral health support such as psychiatry and therapy, all aimed at enhancing the quality of life for individuals facing these challenging conditions.

Verana Health, Inc. is a digital health company based in San Francisco, California, that specializes in transforming healthcare data into actionable insights. Founded in 2008 and formerly known as Digisight Technologies, the company connects healthcare providers with patients through innovative solutions. Its flagship product, SightBook, is a mobile application that enables users to test their vision and share results with their physicians in real-time, facilitating timely appointments and treatments. Verana Health manages data from over 20,000 healthcare providers and 70 electronic health record systems, leveraging its AI-enhanced platform, VeraQ™, to create a robust healthcare data ecosystem. By utilizing advanced analytics on curated datasets, Verana Health supports life sciences partners in improving clinical research and enhancing patient care outcomes.

Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.

Quartet Health is a New York-based company that develops a cloud-based platform designed to enhance communication and collaboration between medical providers and behavioral health providers for patient care. Founded in 2014, Quartet's platform works with health plans and systems to deliver actionable insights and reports on behavioral health conditions, aiming to improve patient outcomes. The platform also offers tools for patient self-management and ensures that mental health care is tailored to individual preferences and clinical needs, while being integrated with the broader healthcare experience and insurance coverage.

Ankyra is a biotechnology company focused on developing anchored immunotherapy for cancer treatment. The company addresses the limitations of traditional cytokine therapies, which are often restricted due to widespread immune activation and associated toxicity. Ankyra's innovative approach involves the use of its Anchored Immunotherapy Platform to create ANK-101, a stable complex of a modified IL-12 cytokine and aluminum hydroxide, an FDA-approved adjuvant. This combination allows for targeted intratumoral delivery, enhancing the localized retention and activity of IL-12 while reducing systemic side effects. By optimizing the therapeutic potential of anchored immunotherapy, Ankyra aims to improve treatment outcomes for cancer patients, offering a safer and more effective alternative to conventional therapies.

Infinitus Systems is an AI healthcare company focused on automating phone-based processes to enhance efficiency within the healthcare ecosystem. By streamlining tedious and time-consuming communication tasks, Infinitus aims to improve access to therapy, adherence, and affordability for patients. The company's innovative tool allows users to submit call requests easily, track updates, and receive notifications upon task completion. Infinitus Systems has raised $51.4 million in funding from prominent investors, including Kleiner Perkins, Coatue, and Google Ventures. Through its automation solutions, the company seeks to reduce the complexity and costs associated with back-office administration in the healthcare sector.

Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Patina is a healthcare provider focused on enhancing the aging experience for older adults and their families. The company has developed a care model that prioritizes the unique needs and values of this demographic. By offering personalized and on-demand services, Patina aims to create a healthcare experience that is both human-centered and supportive. This approach allows families to actively participate in the care of their loved ones, ensuring that older adults receive the attention and respect they deserve as they navigate the challenges of aging. Patina's mission is to empower individuals to live their best lives and maintain their dignity as they age.

Modern Age is a health and wellness platform focused on improving the aging process for individuals. It offers health monitoring software that employs computer vision and machine learning to assess skin, hair, and bone health. The platform also integrates data collected from smart bands to create a comprehensive digital record of an individual's well-being. By analyzing this information, Modern Age provides personalized insights and treatment recommendations, empowering users to manage their health more effectively and lead healthier lives as they age.

Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.

Medsaf is a pharmaceutical platform based in Lagos, Nigeria, that facilitates the delivery of medications to hospitals, pharmacies, and clinics. Founded in 2014, the company offers a wide range of products, including antacids, antiviral drugs, anaemia treatments, antiseptics, and vitamins. Medsaf aims to enhance the accessibility of affordable, quality medications through an integrated suite of technologies designed to improve efficiency and transparency in the supply chain. Its services include online product distribution, quality control as a service, and a marketplace that connects healthcare providers with vetted suppliers and logistics partners. Additionally, Medsaf features an embedded finance platform that provides buy-now-pay-later solutions for medication procurement, streamlining the financial aspects of the pharmaceutical supply process.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. The company leverages artificial intelligence to create diagnostic tools that significantly improve the accuracy of echocardiography, with reported enhancements exceeding 90%. Ultromics' technology focuses on analyzing complex data from electrocardiograms, enabling healthcare providers to make informed decisions in diagnosing coronary artery disease. By providing innovative solutions for cardiologists, Ultromics aims to transform cardiovascular diagnostics and improve patient outcomes.

Sonoma Biotherapeutics develops adoptive Treg cell therapies aimed at treating autoimmune and degenerative diseases. The company employs advanced genome editing and target-specific cell therapy to create therapeutic solutions that promote self-tolerance and mitigate harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded in 2019 and headquartered in South San Francisco, California, with an additional office in Seattle, Washington, Sonoma Biotherapeutics combines expertise in Treg biology and proprietary methodologies to advance its therapeutic platform, focusing on developing disease-modifying and potentially curative treatments.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, automates revenue cycle management by interpreting clinical language in patient charts and accurately assigning medical charge codes, reducing operational expenses, improving payment cycles, and enhancing audit readiness. Nym's solution identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. The company also has a research and development center in Tel Aviv-Yafo, Israel.

TMRW Life Sciences is a technology company focused on improving standards of safety, transparency, and accountability in the management of frozen eggs and embryos within the IVF sector. The company has developed the first automated cryo-management platform specifically designed for this purpose, which integrates a digital chain of custody with robotic storage and monitoring solutions. This innovative approach aims to replace traditional manual methods that have remained largely unchanged over the years, thereby significantly reducing the risk of errors that could have serious consequences. Founded in 2018 by Joshua Abram, Alan Murray, and Dr. Jeffrey Port, TMRW combines expertise in fertility, embryology, cryo-management, automation, software development, and robotics to enhance the specimen management process for clinics, facilitating advancements in IVF technology. The company is headquartered in New York, New York.